Abstract: Various embodiments include methods and devices for implementing secure peripheral interface disablement on a computing device. Various embodiments may include receiving a trigger to disable a peripheral interface associated with a peripheral device of the computing device, identifying a physical address of the peripheral interface, and securely removing a mapping of an intermediate physical address of the peripheral interface to the physical address of the peripheral interface.

Abstract: Various embodiments include methods and devices for implementing secure peripheral interface disablement on a computing device. Various embodiments may include receiving a trigger to disable a peripheral interface associated with a peripheral device of the computing device, identifying a physical address of the peripheral interface, and securely removing a mapping of an intermediate physical address of the peripheral interface to the physical address of the peripheral interface.

Abstract: A topical applications is used to treat and prevent the spread of nail infections or onychomycosis caused by bacteria, fungi and other pathogens. The topical application has a composition that comprises, as an active ingredient, at least one species selected from the group consisting of 2,2?-(alkyldioxy) bis-(alkyl-1,3,2-dioxaborinane) and 2,2?-oxybis(alkyl-1,3,2-dioxaborinane). More specifically, the composition comprises, as an active ingredient, at least one member selected from the group consisting of 2,2?-(1-methyltrimethylene dioxy) bis-(4-methyl-1, 3, 2-dioxaborinane) and 2,2?-oxybis (4, 4, 6-trimethyl-1, 3, 2-dioxaborinane).